Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (6): 69-75.doi: 10.6040/j.issn.1671-7554.0.2017.506

Previous Articles     Next Articles

Correlation analysis of treatment methods and medical expenditures of cancer patients in five counties of Shandong Province

HUA Xingxing1, SUN Xiaojie1, ZHAO Deli2, LIU Weidong3, NI Zhisong4, ZOU Yuewei5, MA Zhongfeng6, YAO Nengliang7, WANG Jialin8, WANG Haipeng1   

  1. 1. School of Medicine and Health Management, Shandong University, Key Laboratory of Health Economy and Policy of National Health and Family Planning Commission, Center for Health Management and Policy Reserch, Shandong University, Jinan 250012, Shandong, China;
    2. Feicheng Peoples Hospital, Feicheng 271600, Shandong, China;
    3. Health and Family Planning Commission of Linqu County, Linqu 262600, Shandong, China;
    4. Department of Public Health, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, Shandong, China;
    5. Rushan Center for Disease Control and Prevention, Rushan 264500, Shandong, China;
    6. Wenshang Center for Disease Control and Prevention, Wenshang 272501, Shandong, China;
    7. Department of Public Health Sciences, University of Virginia, Charlottesville 22908, Virginia, USA;
    8. Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan 250117, Shandong, China)〓山〓东〓大〓学〓学〓报〓(医〓学〓版)56卷6期〓-华星星, 等.山东省5县癌症患者治疗方式和医疗费用及其相关性分析〓\=-
  • Published:2022-09-27

PDF (PC)

47

Abstract: Objective To investigate the treatment methods and medical expenditures of cancer patients in rural areas and the relationship between them. Methods According to the geographical location and economic status, 1 003 cancer cases confirmed during 2011 and 2013 were randomly selected from five counties, including patients with breast cancer(female), lung cancer, intestinal cancer and gastric cancer. All patients were surveyed with questionnaire. Results The proportions of patients who were treated with surgery alone, surgery plus chemotherapy, traditional Chinese medicine and other treatments were 21.1%, 53.1%, 8.7% and 17.1%, respectively. The proportions of patients with medical expenditures <20 000, ≥20 000 and <50 000, ≥50 000 and <80 000 and ≥80 000 RMB were 16.3%, 47.2%, 20.8% and 15.7%, respectively. The influencing factors of medical expenditures were age, income, type of cancer, stage of disease and treatment type. Conclusion Cancer patients have to bear heavy medical expenditures, which are closely related to treatment methods. Early medical care, standardized clinical pathway and medical insurance can help to relieve patients’ financial burdens.

Key words: Cancer, Treatment method, Medical expenditure, Correlation analysis

CLC Number: 

  • R195
[1] 陈万青, 郑荣寿, 张思维, 等. 2013年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2017, 26(1): 1-7. CHEN Wanqing, ZHENG Rongshou, ZHANG Siwei, et al. Report of cancer incidence and mortality in China, 2013[J]. China Cancer, 2017, 26(1): 1-7.
[2] 王岩. 不同治疗方法对年轻乳腺癌患者的生存情况及生活质量的影响[J]. 实用癌症杂志, 2016, 31(4): 654-656. WANG Yan. The effect of different treatment methods on the survival and quality of life of young breast cancer patients[J]. The Practical Journal of Cancer, 2016, 31(4): 654-656.
[3] Wintner LM, Giesinger JM, Zabernigg A, et al. Quality of life during chemotherapy in lung cancer patients: results across different treatment lines[J]. Brit J Cancer, 2013, 109(9): 2301-2308.
[4] 邵亚娟,王颖轶,孟长婷,等. 小细胞肺癌77例治疗及预后分析[J]. 中国医学科学院学报, 2010, 32(4): 394-397. SHAO Yajuan, WANG Yingyi, MENG Changting, et al. Treatment and prognosis of 77 cases of small cell lung cancer[J]. Acta Academiae Medicinae Sinicae, 2010, 32(4): 394-397.
[5] 董佩, 毛阿燕, 邱五七, 等. 北京市6种癌症住院费用回顾性分析[J]. 中国医院管理, 2015, 35(5): 35-37. DONG Pei, MAO Ayan, QIU Wuqi, et al. Retrospective analysis of six kinds of cancers’ costs in Beijing City[J]. Chinese Hospital Management,2015, 35(5): 35-37.
[6] 万杏花. 兰州市十年来四种常见癌症住院医疗费用状况和成本效果的趋势性分析[D]. 兰州:兰州大学, 2008.
[7] Janet S, Katherine S, Chunyu Li, et al. Access to cancer care and general medical care services among cancer survivors in the United States: an analysis of 2011 medical expenditure panel survey data[J]. Public Health Rep, 2016, 131(6): 783-790.
[8] Fabre E, Rivera C, Mordant P, et al. Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal[J]. Thorac Cancer, 2015, 6(6): 731-740.
[9] 张晓晶. 乳腺癌的治疗进展[J]. 临床医药文献电子杂志, 2015, 2(34): 7144-7145.
[10] 张玉超, 申虎, 雷海龙, 等. 胃癌治疗的研究进展[J]. 中外医疗, 2010, 29(14): 191-192.
[11] 殷亮, 陈明清. 结直肠癌治疗进展[J]. 昆明医科大学学报, 2012, 33(12): 166-170.
[12] 谌玉佳. 334例肺癌患者终末期治疗的回顾性研究[D]. 北京: 北京中医药大学, 2015.
[13] Li Y, Wang J, Lin F, et al. A methodology for cancer therapeutics by systems pharmacology-based analysis: a case study on breast cancer-related traditional Chinese medicines[J]. PLoS One, 2017, 12(1): e0169363. doi: 10.1371/journal.pone.0169363.
[14] Tseng CY, Lin CH, Wu LY, et al. Potential combinational anti-cancer therapy in non-small cell cancer lung cancer with traditional Chinese medicine Sun-Bai-Pi extract and cisplatin[J]. PLoS One, 2016, 11(5): e0155469. doi: 10.1371/journal.pone.0155469
[15] Tang WR, Yang SH, Yu CT, et al. Long-term effectiveness of combined treatment with traditional Chinese medicine and western medicine on the prognosis of patients with lung cancer[J]. J Altern Complem Med, 2016, 22(3): 212-222.
[16] Tao W, Luo X, Cui B, et al. Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: A systematic review and meta-analysis[J]. Oncotarget, 2015, 6(37): 39725-39739.
[17] 刘跃华, 戴伟, 杨燕绥. 临床姑息治疗的成本-效果研究系统综述: 基于国际临床随机对照研究证据[J]. 中国卫生经济, 2016, 35(5): 13-18. LIU Yuehua, DAI Wei, YANG Yansui. Systematic review on the cost-effectiveness research of palliative care: based on the evidence of randomized controlled trials[J]. Chinese Health Economics, 2016, 35(5): 13-18.
[18] 周海平, 张学强, 张延红, 等. 邯郸地区癌症治疗费用当量值核算与分析[J]. 检验医学与临床, 2017, 14(1): 13-15. ZHOU Haiping, ZHANG Xueqiang, ZHANG Yanhong, et al. Equivalent value calculation and analysis of cancer treatment cost in Handan area[J]. Laboratory Medicine and Clinic, 2017, 14(1): 13-15.
[19] 张义华, 王增珍. 恶性肿瘤患者年住院费用研究[J]. 中国卫生经济, 2006,25(12): 72-73.
[20] Bernard DSM, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer:2001 to 2008[J]. J Clin Oncol, 2011, 29(20): 2821-2826.
[21] Guy GP Jr, Yabroff KR, Ekwueme DU, et al. Heath care expenditure burden among non-elderly cancer survivors, 2008-2012[J]. Am J Prev Med, 2015, 49(6): 489-497.
[22] Davidoff AJ, Erten M, Shaffer T, et al. Out-of-pocket health care expenditure burden for medicare beneficiaries with cancer[J]. Cancer, 2013, 119(6): 1257-1265.
[23] Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: A meta-analysis[J]. Crit Rev Oncol Hematol, 2010, 75(2): 122-137.
[24] 贾翠平. 老年癌症患者住院费用构成及影响因素分析[J]. 中国病案, 2013, 14(2): 63-64. JIA Cuiping. Study on the composition and influential factors of hospitalization costs of old aged cancer patients[J]. Chinese Medical Record, 2013, 14(2): 63-64.
[25] 唐振涛, 张希富, 张文良, 等. 辽宁省癌症患者住院费用影响因素的多元线性回归分析[J]. 中国肿瘤, 2011, 20(10): 716-718. TANG Zhentao, ZHANG Xifu, ZHANG Wenliang, et al. Multiple linear regression analysis of influencing factors of hospitalization cost in patients with cancer in Liaoning province[J]. China Cancer, 2011, 20(10): 716-718.
[26] 景晶, 梁立. 乳腺癌患者治疗方案与住院费用、住院天数的相关性研究[J]. 经济师, 2015(5): 105-106.
[1] WU Ruifang, LI Changzhong. Status and progress of female fertility protection [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 1-7.
[2] LU Qun, ZHAO Lulu. Progress on assisted reproductive technology for women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertilitysparing treatment [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 35-41.
[3] LIN Yun, XIE Yanqiu. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46.
[4] HAN Jing, JIA Chunling. Effects of periodontal basic therapy on postoperative pneumonia in patients with lung cancer before thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 113-118.
[5] XU Xiaofen, ZHU Xiao, MA Wei, LI Na. Influencing factors of cancer pain management disorder in 123 cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 119-124.
[6] FU Jia, WANG Lulu, HU Shuai, CHEN Zheping, LIU Dongyi, LI Qingsong, LU Guodong, ZHANG He, ZHAO Xin, FENG Chang. Effects of different approaches of quadrates lumborum block on postoperative recovery of patients undergoing radical gastrectomy [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 50-57.
[7] GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49.
[8] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[9] Qifeng YANG,Ning ZHANG. Sentinel lymph node biopsy of breast cancer in the era of precision medicine [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5.
[10] WU Xinying, FENG Yiping, CHANG Kaifeng, JIA Xianjie, XUE Fuzhong. Causal association between green space and cancer incidence [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 115-119.
[11] QIN Jing, YANG Fei, CHEN Qian, XIA Handai, LIU Yanguo, WANG Xiuwen. A network meta-analysis of first-line treatment options for patients with advanced driver-gene wild-type and PD-L1 negative non-squamous non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 74-82.
[12] WANG Fuli, SUN Yinping, QIN Jie, RONG Jiansheng. Efficacy of DC-CIK cells combined with EGFR-TKI for 35 elderly patients with advanced EGFR-mutant lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 110-117.
[13] BAO Shuqing, YANG Mingyue, LIU Duanrui, WANG Yunshan, JIA Yanfei. Role of NOX4 in ROS induction by Helicobacter pylori in gastric cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 19-25.
[14] WANG Jing, XIE Yan, LI Peilong, DU Lutao, WANG Chuanxin. Value of abnormal methylation of cg16212145 on GZMB gene in early screening of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 26-34.
[15] SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd